Ahead Therapeutics SL

Where the EU money came from

Funding by EU programme. Amounts are Ahead Therapeutics SL's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Ahead Therapeutics SL led 1 of them as coordinator. Each links to the official record.

• TOLERATEPartner

  An integrated approach to restore tolerance in autoimmune disease

  Horizon Europe · 2022–2026 · Project on CORDIS ↗

  €252ktheir share
• LIPOBITSCoordinator

  Liposome-based Biomimetic Treatment for auto-immune diabetes (T1D)

  Horizon 2020 · 2018–2019 · Project on CORDIS ↗

  €50ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Katholieke Universiteit LeuvenBelgium · 1 shared project
• Universiteit van AmsterdamNetherlands · 1 shared project
• Technische Universitaet DresdenGermany · 1 shared project
• Universiteit AntwerpenBelgium · 1 shared project
• Stichting Amsterdam UmcNetherlands · 1 shared project
• Universitat Autonoma de BarcelonaSpain · 1 shared project
• Sorbonne UniversiteFrance · 1 shared project
• Assistance Publique Hopitaux de ParisFrance · 1 shared project
• Helmholtz-Zentrum Dresden-Rossendorf eVGermany · 1 shared project
• Royal College of Surgeons In IrelandIreland · 1 shared project
• Stichting Sanquin BloedvoorzieningNetherlands · 1 shared project
• Semmelweis EgyetemHungary · 1 shared project
• Innovation Acta SRLItaly · 1 shared project
• European Hematology AssociationNetherlands · 1 shared project
• AnicellsBelgium · 1 shared project
• Immudex ApsDenmark · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• autoimmune diseases
• cells technologies
• diabetes
• entrepreneurship
• pathophysiology
• vaccines